Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
Background: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in...
Guardado en:
Autores principales: | Mohammad Zubaid, Haitham Khraishah, Barrak Alahmad, Wafa Rashed, Mustafa Ridha, Fahad Alenezi, Mohamad Aljarralah, Khalid Al-Marri, Mohammad Almutairi, Khalid Althalji, Abdulhamied Alfaddagh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Ubiquity Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b7303756293643f58a12cc3172822a6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
por: Khalid F Alhabib, et al.
Publicado: (2021) -
Importance of total ischemic time on immediate and longer-term outcomes after primary PCI - The burning need to push harder for pharmacoinvasive therapies!!
por: Prayaag Kini, et al.
Publicado: (2021) -
Percutaneous nephrolithotomy; alarming variables for postoperative bleeding
por: Shakhawan H.A. Said, et al.
Publicado: (2017) -
Impact of genetic variants on major bleeding after percutaneous coronary intervention based on a prospective multicenter registry
por: Jung-Joon Cha, et al.
Publicado: (2021) -
Chronic total occlusion percutaneous coronary intervention during the COVID-19 pandemic: Insights from the PROGRESS-CTO registry
por: Evangelia Vemmou, et al.
Publicado: (2021)